Third Rock Ventures Iii, L.P. is > 10% Shareholder of Voyager Therapeutics, Inc.. Currently has a direct ownership of 3.19 Million shares of VYGR, which is worth approximately $18.3 Million. The most recent transaction as insider was on Feb 02, 2023, when has been sold 1,500,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.19M
0% 3M change
0% 12M change
Total Value Held $18.3 Million

Third Rock Ventures III, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2023
SELL
Other acquisition or disposition
-
1,500,000 Reduced 32.02%
3,185,291 Common Stock
Feb 01 2023
SELL
Open market or private sale
$1,198,943 $9.32 p/Share
128,642 Reduced 2.67%
4,685,291 Common Stock
Jan 31 2023
SELL
Open market or private sale
$1,711,250 $9.25 p/Share
185,000 Reduced 3.7%
4,813,933 Common Stock
Jan 30 2023
SELL
Open market or private sale
$677,250 $9.03 p/Share
75,000 Reduced 1.48%
4,998,933 Common Stock
Jan 27 2023
SELL
Open market or private sale
$451,000 $9.02 p/Share
50,000 Reduced 0.98%
5,073,933 Common Stock
Jan 25 2023
SELL
Open market or private sale
$461,000 $9.22 p/Share
50,000 Reduced 0.97%
5,123,933 Common Stock
Jan 24 2023
SELL
Open market or private sale
$927,000 $9.27 p/Share
100,000 Reduced 1.9%
5,173,933 Common Stock
Jan 23 2023
SELL
Open market or private sale
$498,300 $9.06 p/Share
55,000 Reduced 1.03%
5,273,933 Common Stock
Jan 20 2023
SELL
Open market or private sale
$915,000 $9.15 p/Share
100,000 Reduced 1.84%
5,328,933 Common Stock
Aug 25 2022
SELL
Open market or private sale
$1,244,000 $6.22 p/Share
200,000 Reduced 3.55%
5,428,933 Common Stock
Aug 24 2022
SELL
Open market or private sale
$913,330 $6.09 p/Share
149,972 Reduced 2.6%
5,628,933 Common Stock
Aug 16 2022
SELL
Open market or private sale
$775,874 $6.04 p/Share
128,456 Reduced 2.17%
5,778,905 Common Stock
Aug 15 2022
SELL
Open market or private sale
$820,280 $6.04 p/Share
135,808 Reduced 2.25%
5,907,361 Common Stock
Aug 12 2022
SELL
Open market or private sale
$2,129,803 $6.12 p/Share
348,007 Reduced 5.45%
6,043,169 Common Stock
Sep 19 2018
SELL
Other acquisition or disposition
-
1,500,000 Reduced 19.01%
6,391,176 Common Stock
Jun 20 2018
SELL
Other acquisition or disposition
-
1,500,000 Reduced 15.97%
7,891,176 Common Stock

Also insider at

MYOK
MyoKardia Inc
NTGN
Neon Therapeutics, Inc.
FULC
Fulcrum Therapeutics, Inc. Healthcare
RVMD
Revolution Medicines, Inc. Healthcare
PLRX
PLIANT THERAPEUTICS, INC. Healthcare
RLAY
Relay Therapeutics, Inc. Healthcare
NRIX
Nurix Therapeutics, Inc. Healthcare
JNCE
Jounce Therapeutics, Inc. Healthcare
TRV

Third Rock Ventures Iii, L.P.

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on VYGR

Follow Voyager Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

News

Receive news related to Voyager Therapeutics, Inc.

Track Activities on VYGR